BeStock  

Schrodinger SDGR

US equityMarket cap rank #2783AI medical concept stocks
$22.93 −$3.41 (-12.95%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $23.25 +1.40%
Open$25.82
Prev close$26.34
Day range$22.75 – $26.30
Volume1.88M
Market cap$1.72B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$64.49M+18.7% YoY
Operating profit-$26.13M+43.1% YoY
Net profit-$37.71M-15.0% YoY
Diluted EPS-$0.50-11.1% YoY
Free cash flow-$48.87M+21.6% YoY
Operating cash flow-$47.58M

Revenue, last 8 quarters

$88.3MDec '24$59.6MMar '25$54.8MJun '25$54.3MSep '25$87.2MDec '25$58.6MMar '26$58.9MJun '26$64.5MSep '26

Net profit, last 8 quarters

$-40.2MDec '24$-59.8MMar '25$-43.2MJun '25$-32.8MSep '25$32.5MDec '25$-60.0MMar '26$6.0MJun '26$-37.7MSep '26

Diluted EPS by quarter

-0.55Dec '24-0.82Mar '25-0.59Jun '25-0.45Sep '250.44Dec '25-0.81Mar '260.08Jun '26-0.50Sep '26

Free cash flow by quarter

$-32.0MDec '24$143.5MMar '25$-52.5MJun '25$-62.4MSep '25$-16.1MDec '25$-17.3MMar '26$-34.4MJun '26$-48.9MSep '26

Annual revenue

$108.1MFY20$137.9MFY21$181.0MFY22$216.7MFY23$207.5MFY24$255.9MFY25

Profitability & balance sheet

Gross margin58.5%
Operating margin-49.6%
Net margin-22.0%
Return on equity-19.0%
Return on assets-9.4%
Return on invested capital-14.1%
Current ratio2.75
Liabilities / assets50.7%
Cash & investments$366.36M
Total debt$89.44M
Net cash (debt)$276.92M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • software$40.24M 62.4%
  • Drug Discovery$24.25M 37.6%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $64.49M $58.89M $58.59M $255.87M $87.24M
Total Operating Revenue $64.49M $58.89M $58.59M $255.87M $87.24M
Cost of Revenue $26.24M $26.46M $29.04M $113.26M $29.94M
Gross Profit $38.25M $32.43M $29.55M $142.61M $57.29M
Operating Expense $64.38M $73.98M $78.34M $309.51M $74.45M
Selling and Admin Expenses $30.29M $32.98M $34.52M $136.37M $33.05M
-Selling & Marketing Expense $10.04M $10.27M $11.60M $40.96M $10.34M
-General & Admin Expense $20.25M $22.72M $22.91M $95.41M $22.71M
Research & Development $34.09M $41.00M $43.82M $173.14M $41.40M
Operating Profit -$26.13M -$41.55M -$48.79M -$166.90M -$17.16M
Other Income (Expense) -$11.43M $48.89M -$10.82M $64.57M $50.13M
Gain on Sale of Security -$14.75M $45.87M -$13.49M $48.17M $47.00M
Other Non-Operating Income (Expenses) $3.33M $3.03M $2.66M $16.40M $3.13M
Pretax Profit -$37.56M $7.35M -$59.62M -$102.33M $32.97M
Tax $156,000.00 $1.37M $408,000.00 $939,000.00 $462,000.00
Net Profit -$37.71M $5.98M -$60.03M -$103.27M $32.51M
Profit from Continuing Operations -$37.71M $5.98M -$60.03M -$103.27M $32.51M
Net Income to Parent Company -$37.71M $5.98M -$60.03M -$103.27M $32.51M
Net Income to Common Stockholders -$37.71M $5.98M -$60.03M -$103.27M $32.51M
Basic EPS -$0.50 $0.08 -$0.81 -$1.41 $0.44
Diluted EPS -$0.50 $0.08 -$0.81 -$1.41 $0.44
Earnings from Equity Interest – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $611.94M $640.39M $634.19M $726.16M $726.16M
Total Current Assets $456.54M $470.48M $463.96M $519.27M $519.27M
Cash and Cash Equivalents & Short-Term Investments $366.36M $413.74M $398.96M $395.46M $395.46M
-Cash and Cash Equivalents $246.98M $287.85M $260.26M $230.52M $230.52M
-Short Term Investments $119.38M $125.89M $138.70M $164.95M $164.95M
Receivables $70.84M $41.12M $48.18M $104.39M $104.39M
-Accounts Receivable $48.36M $21.39M $27.25M $83.04M $83.04M
-Other Receivables $22.47M $19.73M $20.93M $21.35M $21.35M
Prepaid Assets $12.33M $10.55M $9.35M $12.54M $12.54M
Restricted Cash $7.02M $5.06M $7.46M $6.87M $6.87M
Total Non-Current Assets $155.40M $169.92M $170.23M $206.90M $206.90M
Net PPE $116.60M $120.37M $120.65M $122.19M $122.19M
-Gross PPE $116.60M $120.37M $120.65M $147.19M $147.19M
Investments and Advances $27.09M $39.05M $39.83M $73.65M $73.65M
-Long Term Equity Investment $27.09M $39.05M $39.83M $73.65M $73.65M
Goodwill and Other Intangible Assets $4.79M $4.79M $4.79M $4.79M $4.79M
-Goodwill $4.79M $4.79M $4.79M $4.79M $4.79M
Other Non-Current Assets $6.91M $5.71M $4.97M $6.27M $6.27M
Total Liabilities $310.11M $311.44M $320.64M $362.11M $362.11M
Total Current Liabilities $166.29M $173.85M $169.54M $189.14M $189.14M
Payables $7.95M $10.32M $11.95M $11.45M $11.45M
-Accounts Payable $7.95M $10.32M $11.95M $11.45M $11.45M
Current Accrued Expenses $45.49M $42.27M $38.47M $48.42M $48.42M
Short-Term Debt and Capital Lease Obligation $15.19M $16.48M $16.01M $16.41M $16.41M
-Current Capital Lease Obligation $15.19M $16.48M $16.01M $16.41M $16.41M
Current Deferred Liabilities $97.67M $104.77M $103.11M $112.85M $112.85M
Total Non-Current Liabilities $143.82M $137.59M $151.10M $172.97M $172.97M
Long Term Debt and Capital Lease Obligation $89.44M $91.50M $90.94M $92.82M $92.82M
-Long Term Capital Lease Obligation $89.44M $91.50M $90.94M $92.82M $92.82M
Non-Current Deferred Liabilities $53.56M $45.15M $59.02M $78.88M $78.88M
Other Non-Current Liabilities $816,000.00 $939,000.00 $1.14M $1.28M $1.28M
Total Equity $301.83M $328.96M $313.55M $364.05M $364.05M
Stockholders' Equity $301.83M $328.96M $313.55M $364.05M $364.05M
Capital Stock $751,000.00 $748,000.00 $746,000.00 $737,000.00 $737,000.00
-Common Stock $751,000.00 $748,000.00 $746,000.00 $737,000.00 $737,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.02B $1.01B $1.00B $992.02M $992.02M
Retained Earnings -$720.57M -$682.86M -$688.83M -$628.81M -$628.81M
Gains/Losses Not Affecting Retained Earnings -$131,000.00 -$54,000.00 -$28,000.00 $107,000.00 $107,000.00
-Accumulated Depreciation – – – -$25.00M -$25.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$47.58M -$34.07M -$14.83M $13.90M -$16.09M
Net cash flow from continuing operations -$47.58M -$34.07M -$14.83M $13.90M -$16.09M
Net Income from Continuing Operations -$37.71M $5.98M -$60.03M -$103.27M $32.51M
Gain/Loss from Continuing Operations -$6,000.00 -$12,000.00 $11,000.00 $20,000.00 $0.00
Depreciation & Depletion & Amortization $1.46M $1.49M $1.48M $6.02M $1.44M
Change in Working Capital -$33.45M -$4.90M $21.81M $118.17M -$13.47M
-Change in Receivables -$29.71M $7.06M $56.21M $150.94M -$46.99M
-Change in Prepaid Assets -$2.99M -$1.94M $4.49M -$2.45M $1.45M
-Change in Payables and Accrued Expense $842,000.00 $1.87M -$9.55M -$1.85M $14.85M
-Change in Other Current Assets $3.49M $2.73M $2.54M $9.15M $2.37M
-Change in Other Current Liabilities -$3.36M -$2.41M -$2.27M -$8.60M -$2.21M
-Change In Other Working Capital -$1.72M -$12.21M -$29.60M -$29.03M $17.06M
Net cash flow from investing $5.94M $58.62M $44.60M $57.90M $71.41M
Net Cash Flow from Continuing Investing Activities $5.94M $58.62M $44.60M $57.90M $71.41M
Net PPE Purchase and Sale -$1.29M -$362,000.00 -$2.51M -$1.44M -$41,000.00
Net Business Purchase and Sale $500,000.00 $46.64M $20.33M $17.74M $17.74M
Net Investment Purchase and Sale $6.73M $12.34M $26.77M $41.61M $53.71M
Financing Cash Flow $2.72M $650,000.00 $569,000.00 $2.93M $197,000.00
Net Cash Flow from Continuing Financing Activities $2.72M $650,000.00 $569,000.00 $2.93M $197,000.00
Net Issuance Payments Of Debt -$10,000.00 -$15,000.00 -$14,000.00 -$58,000.00 -$15,000.00
Proceeds from Stock Option Exercised $2.73M $665,000.00 $583,000.00 $2.99M $212,000.00
Ending Cash Balance $254.00M $292.92M $267.72M $237.39M $237.39M
Net Change in Cash -$38.91M $25.20M $30.33M $74.73M $55.51M
Beginning Cash Balance $292.92M $267.72M $237.39M $162.66M $181.87M
Free Cash Flow -$48.87M -$34.43M -$17.34M $12.46M -$16.13M
Net Common Stock Issuance – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on SDGR.

Sign in to join the discussion.

Scroll to Top